SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-010427
Filing Date
2024-03-19
Accepted
2024-03-19 08:30:54
Documents
70
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2408085
2 ex10-16.htm EX-10.16 58178
3 ex23-1.htm EX-23.1 3523
4 ex31-1.htm EX-31.1 12233
5 ex31-2.htm EX-31.2 11870
6 ex32-1.htm EX-32.1 6502
7 ex32-2.htm EX-32.2 6494
8 form10-k_001.jpg GRAPHIC 61474
9 form10-k_002.jpg GRAPHIC 54212
10 form10-k_003.jpg GRAPHIC 93931
11 form10-k_004.jpg GRAPHIC 76215
  Complete submission text file 0001493152-24-010427.txt   9003880

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE lixt-20231231.xsd EX-101.SCH 48473
13 XBRL CALCULATION FILE lixt-20231231_cal.xml EX-101.CAL 41160
14 XBRL DEFINITION FILE lixt-20231231_def.xml EX-101.DEF 255068
15 XBRL LABEL FILE lixt-20231231_lab.xml EX-101.LAB 436438
16 XBRL PRESENTATION FILE lixt-20231231_pre.xml EX-101.PRE 345704
73 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1153210
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39717 | Film No.: 24761173
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)